Breakthrough Resistant Hypertension Treatment in China: Renal Denervation (RDN)
- MedBridge NZ
- Oct 5, 2025
- 3 min read
Updated: Feb 21
Key Takeaways:
Targeted Relief: Renal Denervation (RDN) is a minimally invasive procedure designed for patients who do not respond to multiple blood pressure medications.
Proven Efficacy: By calming overactive sympathetic nerves in the renal arteries, RDN helps stabilize blood pressure and reduce the need for heavy medication.
Official Approval: The RDN ablation catheter is officially approved by China's National Medical Products Administration (NMPA) as a safe and effective clinical technology.
Seamless Access: International patients can access this advanced resistant hypertension treatment in China through a dedicated medical concierge provider, eliminating language and logistical barriers.
"My blood pressure has finally stabilized, and I'm even taking two fewer medications. I never expected the results to be this good!"
These are the words of Mr. Liu, a 35-year-old patient who battled severe high blood pressure for over seven years. His condition had escalated to acute left heart failure, and a complex cocktail of medications failed to bring it under control. However, after undergoing a single, advanced resistant hypertension treatment in China, his blood pressure is now within the ideal range, dramatically improving his quality of life.
The Challenge of Stubborn High Blood Pressure
Resistant hypertension affects approximately 4-20% of hypertensive patients worldwide. It is a frustrating condition where blood pressure remains dangerously high despite the concurrent use of three or more antihypertensive drugs.
Before exploring new therapies, a comprehensive medical evaluation is crucial. Doctors must conduct systematic screening to rule out secondary causes, such as renal artery stenosis, kidney disease, or endocrine disorders. Yet, even when these factors are ruled out, some patients remain unresponsive to conventional drugs.
Renal Denervation (RDN): A Minimally Invasive Innovation
To address this critical gap in care, an innovative therapy known as percutaneous renal sympathetic nerve radiofrequency ablation—or Renal Denervation (RDN)—has emerged as a game-changer.
This cutting-edge technique works by precisely targeting and inhibiting overactive sympathetic nerves in the renal arteries, a primary driver of chronic high blood pressure. Based on its significant clinical success, the RDN ablation catheter has received official approval from China's National Medical Products Administration. It is now recognized as a safe, effective, and authoritative clinical technology.
A Real Patient's Journey to Recovery
The effectiveness of RDN is best illustrated by clinical results. Four months prior to his RDN procedure, Mr. Liu was hospitalized for acute heart failure. Despite intensive drug therapy, his 24-hour ambulatory blood pressure averaged a dangerous 152/92 mmHg, leading to severe target organ damage, including ventricular hypertrophy and renal insufficiency.
During the RDN procedure, surgeons successfully ablated 60 points along the main trunk and branches of his renal arteries. Just two months later, his blood pressure stabilized around 110/80 mmHg—even after his medical team reduced two of his daily medications.
The Future of Hypertension Management
Thanks to its safety profile and long-lasting effects, RDN is now recommended in several domestic and international medical guidelines. Today, RDN joins lifestyle interventions and drug therapy to form the "troika" of comprehensive blood pressure management.
Medical researchers in China are continuously advancing this field, seeking biological markers to perfectly match the right patients with RDN therapy, pushing the boundaries of precision medicine.
Author Note: The medical insights in this article are based on the clinical expertise of Dr. Jianzhong Xu, Chief Physician of the Department of Hypertension at Ruijin Hospital, Affiliated with Shanghai Jiao Tong University School of Medicine.
Take the Next Step for Your Heart Health
Living with resistant hypertension can be exhausting, but you don't have to navigate complex overseas healthcare systems alone.
As a specialized medical concierge provider, the MedBridgeNZ team is dedicated to connecting international patients with world-class medical experts in China, including specialists at renowned institutions like Ruijin Hospital. Please note that we do not provide medical services ourselves; instead, we handle the logistics, hospital appointments, medical translation, and travel arrangements so you can focus entirely on your health and recovery.
Are you ready to explore if RDN therapy is the right choice for you?
References:
Farewell to Refractory Hypertension: Ruijin Hospital's New Technology Makes Blood Pressure "Obedient". (2025, July 3). Retrieved from https://sghexport.shobserver.com/html/baijiahao/2025/07/03/1605530.html
